METABOLIC SYNDROME AS A CONTRIBUTOR TO CARDIOVASCULAR LISEASE IN GOUT: A CLINICAL EVALUATION
Keywords:
Gout, Metabolic Syndrome, Cardiovascular Disease, Arterial Hypertension, Ischemic Heart Disease, Myocardial Infarction, Chronic Heart Failure, Obesity, Dyslipidemia, Insulin ResistanceAbstract
Gout, a condition characterized by the deposition of monosodium urate crystals in joints, has long been associated with metabolic disorders. Recent studies indicate that gout patients are at an elevated risk for developing cardiovascular diseases (CVD), particularly in the presence of metabolic syndrome (MS). This study aims to evaluate the prevalence of MS and its relationship with various cardiovascular pathologies, including arterial hypertension (AH), ischemic heart disease (IHD), myocardial infarction (MI), and chronic heart failure (CHF) in a cohort of 90 gout patients. The results show a significant association between MS and increased cardiovascular morbidity in gout patients. Age, obesity, and hypertension are identified as major contributing factors to the development and progression of both MS and cardiovascular diseases in this population.
